
Sign up to save your podcasts
Or


Stereotaxis is developing robotic capabilities to enhance procedures for treating atrial fibrillation, with several innovations in the works. In this Vanguards of Health Care podcast episode, CEO David Fischel sits down with Bloomberg Intelligence analyst Matt Henriksson for a discussion about how the company’s Robotic Navigation System helps patients and future prospects for the use of robotics in cardiology surgery.
See omnystudio.com/listener for privacy information.
By Bloomberg5
33 ratings
Stereotaxis is developing robotic capabilities to enhance procedures for treating atrial fibrillation, with several innovations in the works. In this Vanguards of Health Care podcast episode, CEO David Fischel sits down with Bloomberg Intelligence analyst Matt Henriksson for a discussion about how the company’s Robotic Navigation System helps patients and future prospects for the use of robotics in cardiology surgery.
See omnystudio.com/listener for privacy information.

32,082 Listeners

2,173 Listeners

1,855 Listeners

1,087 Listeners

56,444 Listeners

10,229 Listeners

325 Listeners

67 Listeners

5,458 Listeners

33 Listeners

16,144 Listeners

20 Listeners

510 Listeners

1,330 Listeners

36 Listeners